Perkbox announces new CEO as it supercharges its response to the cost-of-living crisis
LONDON, Dec. 6, 2023 /PRNewswire/ — Perkbox, the largest independent UK perks and benefits provider, has appointed Doug Butler as CEO. With extensive financial and operational expertise, Butler will be charged with driving continued global growth, overseeing product innovation and ensuring con
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ — AstraZeneca’s Koselugo (selumetinib) is now available in Malaysia as a monotherapy for the treatment of paediatric patients three years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neur
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest results of the single-arm, phase II pivotal clinical study for iparomlimab (QL1604), an innovative Class 1 antibody monotherapy used to treat unresectable or metastatic dMMR/MSI-H solid tumors through a poster p
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics
Premium vector technology will improve the production of high-yielding mammalian cell lines SAN DIEGO, Dec. 6, 2023 /PRNewswire/ — Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium protein
Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma
XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved in Macau. XPOVIO® has received regulatory approvals in 42 countries and regions including Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore and Australia. SHANGHAI AND HONG KONG, D
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — WuXi Vaccines, a leading global vaccine CDMO (Contract Development and Manufacturing Organization), today announced it has successfully passed an on-site GMP audit by a global vaccine leader at its first standalone CDMO site in Suzhou, China. The audi
TerraQuest’s KeyChain Platform Awarded Trusted Product Maintainability v15.0 Certification
AMSTERDAM, Dec. 6, 2023 /PRNewswire/ — TerraQuest (TQ), a leading provider of innovative data management solutions, was proudly awarded the SIG/TÜViT certification for Trusted Product Maintainability for the TQ KeyChain Platform. Software Improvement Group (SIG) was a key partner in improvin
CME Group to Launch FX Spot+ to Connect OTC and Futures Liquidity
CHICAGO and LONDON, Dec. 6, 2023 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that it will launch CME FX Spot+, a new, all-to-all spot FX marketplace that will connect cash market participants with the company’s FX futures liquidity. The of
UCLA Anderson Forecast Says, Despite Geopolitical Uncertainty, Data Indicate No Recession
California’s slower-growing economy continues to outpace the weak growth of the U.S. economy LOS ANGELES, Dec. 6, 2023 /PRNewswire/ — In its fourth and final economic forecast of 2023, the UCLA Anderson Forecast says that the threat of imminent recession has faded. This development resul
VERTICAL INSTITUTE REVOLUTIONISES CAREER DEVELOPMENT WITH CUTTING-EDGE COURSES AND EXPERT-LED INSTRUCTION
Vertical Institute (VI) is a leading provider of cutting-edge courses, addressing the critical need for upskilling and reskilling in the rapidly evolving job market, with a focus on future-proofing careers.Accredited as an Approved Training Provider by SkillsFuture Singapore and The Institute of Ban